GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BB Biotech AG (LSE:0JYO) » Definitions » Cyclically Adjusted Book per Share

BB Biotech AG (LSE:0JYO) Cyclically Adjusted Book per Share : €0.00 (As of Mar. 2024)


View and export this data going back to . Start your Free Trial

What is BB Biotech AG Cyclically Adjusted Book per Share?

Note: As Cyclically Adjusted Book per Share is a main component used to calculate Cyclically Adjusted PB Ratio. If the month end stock price for this stock is zero, result may not be accurate due to the exchange rate between different shares and the data will not be stored into our database. Selected historical data showed in the calculation section below is only for demostration purpose.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

BB Biotech AG's adjusted book value per share for the three months ended in Mar. 2024 was €226.246. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €0.00 for the trailing ten years ended in Mar. 2024.

During the past 12 months, BB Biotech AG's average Cyclically Adjusted Book Growth Rate was 6.50% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 6.30% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 5.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of BB Biotech AG was 6.30% per year. The lowest was 3.10% per year. And the median was 4.35% per year.

As of today (2024-06-14), BB Biotech AG's current stock price is €189.39. BB Biotech AG's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was €0.00. BB Biotech AG's Cyclically Adjusted PB Ratio of today is .

During the past 13 years, the highest Cyclically Adjusted PB Ratio of BB Biotech AG was 1.27. The lowest was 0.96. And the median was 1.15.


BB Biotech AG Cyclically Adjusted Book per Share Historical Data

The historical data trend for BB Biotech AG's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BB Biotech AG Cyclically Adjusted Book per Share Chart

BB Biotech AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

BB Biotech AG Quarterly Data
Sep16 Dec16 Mar17 Jun17 Dec17 Dec18 Dec19 Dec20 Mar21 Jun21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of BB Biotech AG's Cyclically Adjusted Book per Share

For the Biotechnology subindustry, BB Biotech AG's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BB Biotech AG's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BB Biotech AG's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where BB Biotech AG's Cyclically Adjusted PB Ratio falls into.



BB Biotech AG Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, BB Biotech AG's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book= Book Value per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=226.246/107.3549*107.3549
=226.246

Current CPI (Mar. 2024) = 107.3549.

BB Biotech AG Quarterly Data

Book Value per Share CPI Adj_Book
201109 51.230 101.811 54.020
201112 55.251 101.408 58.491
201203 62.695 101.826 66.099
201206 69.933 101.596 73.897
201209 100.476 101.392 106.385
201212 89.855 100.968 95.539
201303 96.554 101.221 102.405
201306 104.995 101.466 111.088
201309 139.102 101.336 147.365
201312 152.255 101.036 161.778
201403 151.694 101.224 160.882
201406 165.959 101.517 175.503
201409 202.782 101.247 215.016
201412 256.518 100.704 273.460
201503 308.642 100.339 330.224
201506 340.777 100.464 364.153
201509 279.847 99.785 301.076
201512 324.156 99.386 350.146
201603 210.034 99.475 226.672
201606 212.549 100.088 227.982
201609 243.664 99.604 262.625
201612 246.671 99.380 266.467
201703 265.352 100.040 284.755
201706 270.325 100.285 289.382
201712 267.594 100.213 286.665
201812 225.782 100.906 240.212
201912 274.500 101.063 291.589
202012 317.713 100.241 340.261
202103 0.000 100.800 0.000
202106 0.000 101.352 0.000
202112 278.686 101.776 293.964
202203 238.246 103.205 247.826
202206 217.020 104.783 222.347
202209 0.000 104.835 0.000
202212 240.418 104.666 246.594
202303 202.877 106.245 204.997
202306 204.856 106.576 206.354
202309 203.697 106.570 205.198
202312 217.590 106.461 219.417
202403 226.246 107.355 226.246

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


BB Biotech AG  (LSE:0JYO) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of BB Biotech AG was 1.27. The lowest was 0.96. And the median was 1.15.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


BB Biotech AG Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of BB Biotech AG's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


BB Biotech AG (LSE:0JYO) Business Description

Industry
Traded in Other Exchanges
Address
Schwertstrasse 6, Schaffhausen, CHE, CH-8200
BB Biotech AG is a part of the healthcare sector in Switzerland. Its primary activity includes making investments, especially in the biotechnology market and is one of the largest investors in the field of biotechnology. The focus of the investments is on those listed companies that focus on the development and marketing of novel drugs with a clear value for the healthcare system. BB Biotech follows a strategy of carefully screening and selecting biotechnology firms with a long-term time horizon and having established products in the marketplace. Geographically it earns key revenue from the Netherlands.

BB Biotech AG (LSE:0JYO) Headlines

No Headlines